About Index Trending news
Analyze
Top 50 Pricing
Fab'entech

Fab'entech

Work at Fab'entech? Add yourself to this profile

Fab'entech

#Biopharmaceutical company specialized in passive immunotherapy based on specific polyclonal immunoglobulins [F(ab')2] against emerging #infectiousdiseases.

Elsewhere

Alexa global traffic share

Twitter followers

16 May 2014
$4,128,628
Venture capital (Series A)